Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation

Journal of Interventional Cardiac Electrophysiology

Volumn 37, Issue 3, 2013, Pages 233-239

  Haines, David E ^a,f   Mead Salley, Michelle ^a   Salazar, Miguel ^a   Marchlinski, Francis E ^b   Zado, Erica ^b   Calkins, Hugh ^c   Yarmohammadi, Hirad ^c   Nademanee, Koonlawee ^d   Amnueypol, Montawatt ^d   Skanes, Allan C ^e   Saklani, Pradyot ^e  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d Pacific Rim EP Research Institute Center   (United States)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Anticoagulation; Atrial fibrillation; Catheter ablation; Dabigatran; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; DABIGATRAN; DALTEPARIN; ENOXAPARIN; FRESH FROZEN PLASMA; HEPARIN; PROTAMINE; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIAC PATIENT; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRYOPRECIPITATE; DRUG EFFICACY; DRUG SAFETY; EMBOLISM; ERYTHROCYTE CONCENTRATE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; TRANSIENT ISCHEMIC ATTACK;

ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; CANADA; CATHETER ABLATION; COMORBIDITY; DECISION MAKING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EVIDENCE-BASED MEDICINE; HUMANS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RISK FACTORS; THROMBOEMBOLISM; TREATMENT OUTCOME; UNITED STATES; WARFARIN;

EID: 84882252949     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-013-9800-z     Document Type: Article

References (28)

1. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2012; 9:632-696.
2. Sorgente, A.; Chierchia, G. B.; de Asmundis, C.; Sarkozy, A.; Capulzini, L.; & Brugada, P. (2011). Complications of atrial fibrillation ablation: when prevention is better than cure. Europace, 13, 1526-1532.
3. Bohnen, M.; Stevenson, W. G.; Tedrow, U. B.; Michaud, G. F.; John, R. M.; Epstein, L. M.; et al. (2011). Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm, 8, 1661-1666.
4. Cappato, R.; Calkins, H.; Chen, S. A.; Davies, W.; Iesaka, Y.; Kalman, J.; et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3, 32-38.
5. Oral, H.; Chugh, A.; Ozaydin, M.; Good, E.; Fortino, J.; Sankaran, S.; et al. (2006). Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation, 114, 759-765.
6. Scherr, D.; Sharma, K.; Dalal, D.; Spragg, D.; Chilukuri, K.; Cheng, A.; et al. (2009). Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 20, 1357-1363.
7. Gaita, F.; Caponi, D.; Pianelli, M.; Scaglione, M.; Toso, E.; Cesarani, F.; et al. (2010). Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation, 122, 1667-1673.
8. Herrera Siklody, C.; Deneke, T.; Hocini, M.; Lehrmann, H.; Shin, D. I.; Miyazaki, S.; et al. (2011). Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation comparison of different atrial fibrillation ablation technologies in a multicenter study. Journal of the American College of Cardiology, 58, 681-688.
9. Hoyt, H.; Bhonsale, A.; Chilukuri, K.; Alhumaid, F.; Needleman, M.; Edwards, D.; et al. (2011). Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm, 8, 1869-1874.
10. Baman, T. S.; Jongnarangsin, K.; Chugh, A.; Suwanagool, A.; Guiot, A.; Madenci, A.; et al. (2011). Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 22, 626-631.
11. Ren, J. F.; Marchlinski, F. E.; Callans, D. J.; Gerstenfeld, E. P.; Dixit, S.; Lin, D.; et al. (2005). Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. Journal of Cardiovascular Electrophysiology, 16, 474-477.
12. Wazni, O. M.; Beheiry, S.; Fahmy, T.; Barrett, C.; Hao, S.; Patel, D.; et al. (2007). Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation, 116, 2531-2534.
13. Hakalahti, A.; Uusimaa, P.; Ylitalo, K.; & Raatikainen, M. J. (2011). Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace, 13, 640-645.
14. Winkle, R. A.; Mead, R. H.; Engel, G.; Kong, M. H.; & Patrawala, R. A. (2012). The use of dabigatran immediately after atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology, 23, 264-268.
15. Khairy, P.; Chauvet, P.; Lehmann, J.; Lambert, J.; Macle, L.; Tanguay, J. F.; et al. (2003). Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation, 107, 2045-2050.
16. Grimm, R. A.; Stewart, W. J.; Maloney, J. D.; Cohen, G. I.; Pearce, G. L.; Salcedo, E. E.; et al. (1993). Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. Journal of the American College of Cardiology, 22, 1359-1366.
17. Sparks, P. B.; Jayaprakash, S.; Mond, H. G.; Vohra, J. K.; Grigg, L. E.; & Kalman, J. M. (1999). Left atrial mechanical function after brief duration atrial fibrillation. Journal of the American College of Cardiology, 33, 342-349.
18. Stangier, J. (2008). Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clinical Pharmacokinetics, 47, 285-295.
19. Battinelli, E. M. (2011). Reversal of new oral anticoagulants. Circulation, 124, 1508-1510.
20. Connolly, S. J.; Ezekowitz, M. D.; Yusuf, S.; Eikelboom, J.; Oldgren, J.; Parekh, A.; et al. (2009). Dabigatran versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine, 361, 1139-1151.
21. Pradaxa [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc. May 2012. http://bidocs.boehringer-ingelheim.com/ BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/ Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf. Accessed 18 June 2012.
22. Di Biase, L.; Burkhardt, J. D.; Mohanty, P.; Sanchez, J.; Horton, R.; Gallinghouse, G. J.; et al. (2010). Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation, 121, 2550-2556.
23. Santangeli, P.; Di Biase, L.; Horton, R.; Burkhardt, J. D.; Sanchez, J.; Al-Ahmad, A.; et al. (2012). Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis. Circulation. Arrhythmia and Electrophysiology, 5, 302-311.
24. Ren, J. F.; Marchlinski, F. E.; & Callans, D. J. (2004). Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. Journal of the American College of Cardiology, 43, 1861-1867.
25. van Ryn, J.; Stangier, J.; Haertter, S.; Liesenfeld, K. H.; Wienen, W.; Feuring, M.; et al. (2010). Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thrombosis and Haemostasis, 103, 1116-1127.
26. Lakkireddy, D.; Reddy, Y. M.; Di Biase, L.; Vanga, S. R.; Santangeli, P.; Swarup, V.; et al. (2012). Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Journal of the American College of Cardiology, 59, 1168-1174.
27. Bauer, K. A. (2011). Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa. Journal of Thrombosis and Haemostasis, 9(Suppl 1), 12-19.
28. Kim, J. S.; She, F.; Jongnarangsin, K.; Chugh, A.; Latchamsetty, R.; Ghanbari, H.; et al. (2012). Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm.